Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies

British Journal of Clinical Pharmacology

Volumn 46, Issue 1, 1998, Pages 29-35

  Cross, Sheree E ^a   Anderson, Chris ^b   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glycolsalicylate; Methylsalicylate; Percutaneous; Triethanolamine

Indexed keywords

SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; TRIETHANOLAMINE;

ARTICLE; DRUG ABSORPTION; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MICRODIALYSIS; PRIORITY JOURNAL; SKIN; SKIN PENETRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; CELLS, CULTURED; DIFFUSION; FEMALE; HUMANS; HYDROLYSIS; MALE; MICRODIALYSIS; SALICYLATES; SKIN; SKIN ABSORPTION;

EID: 0031859098     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00045.x     Document Type: Article

References (24)

1. Dawson M, McGee CM, Vine JH, Nash P, Watson TR, Brooks PM. The disposition of biphenylacetic acid following topical application. Eur J Clin Pharmacol 1988; 33: 639-642.
2. Schaefer H, Redelmeier TE. The practical application of techniques to measure percutaneous absorption. In Skin Barrier. Principles of Percutaneous Absorption. Basel: Karger, 1996: 213-249.
3. Kao J, Carver MP. Cutaneous metabolism of xenobiotics. Drug Metab Rev 1990; 22: 363-410.
4. Roberts MS, Favretto WA, Meyer A, Reckmann M, Wongseelashote T. Topical bioavailability of methylsalicylate. Aust N Z J Med 1982; 12: 303-305.
5. Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30: 935-940.
6. Danon A, Ben-Shimon S, Ben-Zvi Z. Effect of exercise and heat exposure on percutaneous absorption of methyl salicylate. Eur J Clin Pharmacol 1986; 31: 49-52.
7. Anderson C, Andersson T, Molander M. Ethanol absorption across human skin measured by vivo microdialysis technique. Acta Derm Venerol 1991; 71: 389-393.
8. Anderson C, Andersson T, Andersson RGG. In vivo microdialysis estimation of histamine in human skin. Skin Pharmacol 1992; 5: 177-183.
9. Anderson C, Andersson T, Boman A, Molander M. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Prob Dematol 1996; 25: 37-46.
10. Müller M, Schmidt R, Wagner O, Osten BV, Shayganfar H, Eichler HG. In vivo characterisation of transdermal transport by microdialysis. J Contr Rel 1995; 57: 49-57.
11. Hegemann L, Forstinger C, Partsch B, Lagler I, Krotz S, Wolff K. Microdialysis in cutaneous pharmacology: Kinetic analysis of transdermally delivered nicotine. J Invest Dermatol 1995; 104: 839-843.
12. Anderson C, Andersson T, Nyquist-Mayer A, Melin M, Roberts MS. Cutaneous microdialysis technique in the study of the percutaneous absorption of a local anaesthetic cream in vivo in human skin. In Perspectives in Percutaneous Penetration. Volume 5a. Cardiff: STS Publishing, 1997: 46.
13. Megwa SA, Benson HAE, Roberts MS. Percutaneous absorption of salicylates from commercially available products containing methylsalicylate or salicylate salts in rats. J Pharm Pharmacol 1995; 47: 891-896.
14. Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Phamacokin Biopharm 1993; 21: 337-373.
15. Singh P, Roberts MS. Skin permeability and local tissue concentrations of non-steroidal antiinflammatory drugs (NSAIDs) after topical application. J Pharmacol Exp Ther 1994; 268: 144-151.
16. Cross SE, Anderson C, Thompson MJ, Roberts MS. Is there tissue penetration after application of topical salicylate formulations. Lancet 1997; 350: 636.
17. Boehnlein J, Sakr A, Lichtin JL, Bronough RL. Characterisation of esterase and alcohol dehydrogenase activity in skin: Metabolism of retinyl palmitate to retinol (vitamin A) during percutaneous absorption. Pharm Res 1994; 11: 1155-1159.
18. Neubert R, Partyka D, Wohlrab W, Dettlaff B, Furst W, Taube KM. Penetration of salicylic acid and salicylate into the multilayer membrane system and into the human horny layer. Dermatol Monatsschr 1990; 176: 711-716.
19. Pardo A, Shiri Y, Cohen S. Kinetics of transdermal penetration of an organic pair: physostigmine salicylate. J Pharm Sci 1992; 81: 990-995.
20. Cross SE, Wu ZY, Roberts MS. Effect of perfusion flow rate on the dermal tissue uptake of solutes after dermal application using the isolated perfused rat hindlimb preparation. J Pharm Pharmacol 1994; 46: 844-850.
21. Singh P, Roberts MS. Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharm Sci 1994; 83: 783-791.
22. Radermacher J, Jentsch D, Scholl MA, Lustinetz T. Frolich JC. Diclofenac cancentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991; 31: 537-541.
23. Cross SE, Wu ZY, Roberts MS. The effect of protein binding on the deep tissue penetration and elution of transdermally applied water, salicylic acid, lignocaine and diazepam in the perfused rat hindlimb. J Pharmacol Exp Ther 1996; 277: 366-374.
24. Singh P, Roberts MS. local deep tissue penetration of compounds after dermal application: Structure-tissue penetration relationships. J Pharmacol Exp Ther 1996; 279: 908-917.